Meloxivet™ (meloxicam) Solution for Injection
For use in dogs and cats
In Dogs: For the control of pain and inflammation associated with osteoarthritis.
In Cats: For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery.
Meloxivet™ Solution for Injection provides 5 mg/mL of meloxicam and is available in 10 mL vials.
| Active(s)/Ingredient(s): | meloxicam |
| Pack size(s): | 10ml |
| Documents: | Package insert get_app SDS get_app |
Important safety information
Warning: Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats.
See Contraindications, Warnings, and Precautions for detailed information.
Important Safety Information for Cats: Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer a second dose of meloxicam. Do not follow meloxicam dose with any other NSAID. As a class, cyclo-oxygenase inhibitory NSAIDs may be associated with gastrointestinal, kidney, or liver side effects. The most common side effects reported in field studies were vomiting and soft stool/diarrhea. These are usually mild, but may be serious. If side effects occur, pet owners should halt therapy and contact their veterinarian. Pets should be evaluated for pre-existing conditions and currently prescribed medications prior to treatment with meloxicam then monitored regularly while on treatment. Concurrent use with another NSAID, corticosteroid, or nephrotoxic medication should be avoided. The safe use of meloxicam 5 mg/mL Solution for Injection in cats younger than 4 months of age, cats used for breeding, or in pregnant or lactating queens has not be evaluated. Please refer to the package insert for complete product information.
Important Safety Information for Dogs: As a class, cyclo-oxygenase inhibitory NSAIDs may be associated with gastrointestinal, kidney, or liver side effects. The most common side effects reported in field studies were vomiting and soft stool/diarrhea. These are usually mild, but may be serious. If side effects occur, pet owners should halt therapy and contact their veterinarian. Pets should be evaluated for pre-existing conditions and currently prescribed medications prior to treatment with meloxicam, then monitored regularly while on treatment. Concurrent use with another NSAID, corticosteroid, or nephrotoxic medication should be avoided. The safe use of meloxicam in dogs younger than 6 months of age, dogs used for breeding, or in pregnant or lactating bitches has not been evaluated. Please refer to the package insert for complete product information.
Approved by FDA under ANADA #200-727.
Meloxicam is a trademark of Dechra Veterinary Products, LLC.